688363 華熙生物
按盤價 
63.390 +1.600 (+2.589%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,360,532 | 4.24% | 6,075,924 | 6,359,192 | 4,947,774 | 2,632,734 | |
| 減：營業總成本 | 1,042,740 | -6.91% | 5,438,234 | 5,322,193 | 4,165,938 | 1,925,485 | |
| 其中:營業成本 | 330,182 | -3.51% | 1,621,028 | 1,463,227 | 1,085,252 | 489,470 | |
| 財務費用 | (4,676) | -22.76% | (30,795) | (48,657) | (495) | (512) | |
| 資產減值損失 | (7,136) | -641.82% | (54,403) | (15,447) | (29,828) | (16,257) | |
| 公允價值變動收益 | -- | -- | 1,468 | (143) | 7,394 | 3,339 | |
| 投資收益 | (1,591) | -185.52% | 1,327 | 11,915 | 20,646 | 34,177 | |
| 其中：對聯營企業和合營企業的投資收益 | (2,007) | 240.37% | (1,652) | (2,360) | (344) | (5,964) | |
| 營業利潤 | 300,319 | 23.53% | 708,386 | 1,136,314 | 905,553 | 757,048 | |
| 利潤總額 | 300,605 | 24.35% | 701,722 | 1,136,112 | 890,199 | 758,898 | |
| 減：所得稅費用 | 57,217 | 40.32% | 118,980 | 174,732 | 114,643 | 113,887 | |
| 淨利潤 | 243,388 | 21.11% | 582,742 | 961,380 | 775,556 | 645,011 | |
| 減：非控股權益 | 20 | -95.82% | (9,814) | (9,538) | (6,779) | (828) | |
| 股東淨利潤 | 243,367 | 21.39% | 592,556 | 970,919 | 782,335 | 645,839 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.510 | 21.43% | 1.230 | 2.020 | 1.630 | 1.350 | |
| 每股派息 (元) * | -- | -- | 0.380 | 0.610 | 0.490 | 0.410 | |
| 每股淨資產 (元) * | 14.715 | 2.84% | 14.416 | 13.789 | 11.873 | 10.458 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 17/05/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
